Kaya Holdings (OTCQB:KAYS) Secures Site for The Sacred Mushroom(TM) Planned Psilocybin Treatment Center
State-of-the-Art Facility to Offer Access to Psilocybin TreatmentsFT. LAUDERDALE, FL / ACCESSWIRE / September 28, 2023 / Kaya Holdings, Inc., ("KAYS" or the "Company") (OTCQB:KAYS) announced today that it has secured premium space for its planned …
State-of-the-Art Facility to Offer Access to Psilocybin Treatments
FT. LAUDERDALE, FL / ACCESSWIRE / September 28, 2023 / Kaya Holdings, Inc., ("KAYS" or the "Company") (OTCQB:KAYS) announced today that it has secured premium space for its planned psilocybin treatment center, The Sacred Mushroom.
Seen above, the almost 11,000 square foot space on the top floor of Portland Oregon's iconic Falcon Building offers the Company the opportunity to implement its proprietary and innovative approach to psilocybin treatments.
The Sacred Mushroom, a one-of-a-kind Psilocybin Production and Facilitation Center in Portland, Oregon will be designed to provide visitors with access to its microdosing café, private treatment rooms and group session areas, as well as activity zones that include yoga, listening stations, journaling chairs, and expression through art - delivering a comfortable and relaxing environment for psychedelic treatments.
"This space is ideal for the delivery of effective psilocybin experiences for people with a wide array of treatment resistant mental health disorders," remarked KAYS' CEO Craig Frank. "We intend to reach out to people with PTSD, addictions, eating disorders, and depression to provide access to affordable relief, making The Scared Mushroom a center for healing."
In 2014, KAYS became the first US public company to own and operate a medical cannabis dispensary in the United States and is again seeking to break ground with the planned opening of The Sacred Mushroom Psilocybin Treatment Center. KAYS plans to operate The Sacred Mushroom as part of its Fifth Dimension Therapeutics, Inc. subsidiary ("FDT"), which also plans to work cooperatively with select pharmaceutical companies to maximize the curative potential of psilocybin.
"We believe that the executed lease with the Falcon Building is a significant milestone in our efforts to launch this first location," said W. David Jones, KAYS Sr. Advisor for Business Development and Financial Operations. "The Sacred Mushroom intends to file its Oregon health Authority ("OHA") Licensing application within the next 30 days, as we have already confirmed zoning approval with the City of Portland (through approval of the requisite Land Use Compatibility Statement), and Bryan Arnold (a KAYS employee and vice president of FDT) has already received his OHA Psilocybin Facilitator license which will allow him to oversee the operation at The Sacred Mushroom. " The launch of "The Sacred Mushroom Psilocybin Treatment Center is dependent, among other matters on final OHA licensing and receipt of final financing from our investors.